Furthermore, DCs themselves could also infiltrated into the tumors indicating that IL-2 treatment could promote a sustained T cell immunity to pancreatic cancer not only by generating tumor specific T cells but also upregulating DCs infiltration. Here, IL2 is linked to neoplasm.